Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes

Summary: Preclinical drug candidates are screened for their ability to ameliorate in vitro neuronal electrophysiology, and go/no-go decisions progress drugs to clinical trials based on population means across cells and animals. However, these measures do not mitigate clinical endpoint risk. Populati...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sushmita L. Allam, Timothy H. Rumbell, Tuan Hoang-Trong, Jaimit Parikh, James R. Kozloski
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/1c7b6625b6fe493881da67d82223dbf5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1c7b6625b6fe493881da67d82223dbf5
record_format dspace
spelling oai:doaj.org-article:1c7b6625b6fe493881da67d82223dbf52021-11-20T05:09:15ZNeuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes2589-004210.1016/j.isci.2021.103279https://doaj.org/article/1c7b6625b6fe493881da67d82223dbf52021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589004221012487https://doaj.org/toc/2589-0042Summary: Preclinical drug candidates are screened for their ability to ameliorate in vitro neuronal electrophysiology, and go/no-go decisions progress drugs to clinical trials based on population means across cells and animals. However, these measures do not mitigate clinical endpoint risk. Population-based modeling captures variability across multiple electrophysiological measures from healthy, disease, and drug phenotypes. We pursued optimizing therapeutic targets by identifying coherent sets of ion channel target modulations for recovering heterogeneous wild-type (WT) population excitability profiles from a heterogeneous Huntington’s disease (HD) population. Our approach combines mechanistic simulations with population modeling of striatal neurons using evolutionary optimization algorithms to design ‘virtual drugs’. We introduce efficacy metrics to score populations and rank virtual drug candidates. We found virtual drugs using heuristic approaches that performed better than single target modulators and standard classification methods. We compare a real drug to virtual candidates and demonstrate a novel in silico triaging method.Sushmita L. AllamTimothy H. RumbellTuan Hoang-TrongJaimit ParikhJames R. KozloskiElsevierarticleNeuroscienceSystems neuroscienceIn silico biologyScienceQENiScience, Vol 24, Iss 11, Pp 103279- (2021)
institution DOAJ
collection DOAJ
language EN
topic Neuroscience
Systems neuroscience
In silico biology
Science
Q
spellingShingle Neuroscience
Systems neuroscience
In silico biology
Science
Q
Sushmita L. Allam
Timothy H. Rumbell
Tuan Hoang-Trong
Jaimit Parikh
James R. Kozloski
Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
description Summary: Preclinical drug candidates are screened for their ability to ameliorate in vitro neuronal electrophysiology, and go/no-go decisions progress drugs to clinical trials based on population means across cells and animals. However, these measures do not mitigate clinical endpoint risk. Population-based modeling captures variability across multiple electrophysiological measures from healthy, disease, and drug phenotypes. We pursued optimizing therapeutic targets by identifying coherent sets of ion channel target modulations for recovering heterogeneous wild-type (WT) population excitability profiles from a heterogeneous Huntington’s disease (HD) population. Our approach combines mechanistic simulations with population modeling of striatal neurons using evolutionary optimization algorithms to design ‘virtual drugs’. We introduce efficacy metrics to score populations and rank virtual drug candidates. We found virtual drugs using heuristic approaches that performed better than single target modulators and standard classification methods. We compare a real drug to virtual candidates and demonstrate a novel in silico triaging method.
format article
author Sushmita L. Allam
Timothy H. Rumbell
Tuan Hoang-Trong
Jaimit Parikh
James R. Kozloski
author_facet Sushmita L. Allam
Timothy H. Rumbell
Tuan Hoang-Trong
Jaimit Parikh
James R. Kozloski
author_sort Sushmita L. Allam
title Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
title_short Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
title_full Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
title_fullStr Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
title_full_unstemmed Neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
title_sort neuronal population models reveal specific linear conductance controllers sufficient to rescue preclinical disease phenotypes
publisher Elsevier
publishDate 2021
url https://doaj.org/article/1c7b6625b6fe493881da67d82223dbf5
work_keys_str_mv AT sushmitalallam neuronalpopulationmodelsrevealspecificlinearconductancecontrollerssufficienttorescuepreclinicaldiseasephenotypes
AT timothyhrumbell neuronalpopulationmodelsrevealspecificlinearconductancecontrollerssufficienttorescuepreclinicaldiseasephenotypes
AT tuanhoangtrong neuronalpopulationmodelsrevealspecificlinearconductancecontrollerssufficienttorescuepreclinicaldiseasephenotypes
AT jaimitparikh neuronalpopulationmodelsrevealspecificlinearconductancecontrollerssufficienttorescuepreclinicaldiseasephenotypes
AT jamesrkozloski neuronalpopulationmodelsrevealspecificlinearconductancecontrollerssufficienttorescuepreclinicaldiseasephenotypes
_version_ 1718419528043462656